Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Risk Communication Advisory Cmte. Will Assess Pharmacy Leaflets’ Utility

Executive Summary

FDA's Risk Communication Advisory Committee will meet Feb. 26-27 to discuss how to improve the usability of consumer medical information leaflets distributed by pharmacies with prescription drugs
Advertisement

Related Content

Single Patient Drug Leaflet Logical, Complicated To Achieve - Woodcock
Single Patient Drug Leaflet Logical, Complicated To Achieve - Woodcock
FDA Prepares Prototypes Of Consumer Medical Information Options
DTC Ads To Be Studied By FDA With Eye On Efficacy Presentations
DTC Ads To Be Studied By FDA With Eye On Efficacy Presentations
FDA Poised To Overhaul Distribution Of Consumer Medical Information
Pharmacy Leaflets Become Focus For Patient Safety; IoM, FDA Finalize Standards
FDA Should Create Oversight Body For Consumer Rx Information, Cmte Says
FDA REFORM ACTION DELAYED UNTIL SEPTEMBER AS NEGOTIATIONS CONTINUE OVER AUGUST RECESS; "MEDGUIDE" AUTHORIZED BY FISCAL 1997 FDA APPROPRIATIONS LEGISLATION
FDA REFORM ACTION DELAYED UNTIL SEPTEMBER AS NEGOTIATIONS CONTINUE OVER AUGUST RECESS; "MEDGUIDE" AUTHORIZED BY FISCAL 1997 FDA APPROPRIATIONS LEGISLATION
Advertisement
UsernamePublicRestriction

Register

PS050468

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel